anonymous
Guest
anonymous
Guest
One month with a closing share price under $1. NASDAQ can formally start delisting process. Ricky.
One month with a closing share price under $1. NASDAQ can formally start delisting process. Ricky.
One month with a closing share price under $1. NASDAQ can formally start delisting process. Ricky.
6 months before the deficiency letter so little dickie will be madly trying to find someone to pump and dump to get the price above $1 for a couple weeks to buy some time screw everyone over before the exit. If no sucker to help out, pink sheets by May 2024.
How can they block?Management is blocking a lot of posts on here. What are they afraid of?
How can they block?
Management is blocking a lot of posts on here. What are they afraid of?
Was Ricky brought in to bankrupt the company? If so, who benefits from that?
The Paulson touchSupposedly positive data is released at ASH and the stock tanks. It’s the Karyopharm way.
Supposedly positive data is released at ASH and the stock tanks. It’s the Karyopharm way.
Why doesn’t the board put a stop to this?
What board? The same board that ousted MK and hired RP? That board? Better question is why isn’t the SEC doing anything? Why are none of our institutional investors doing anything?
My guess is, it’s small potatoes, many biotechs go belly up every year with very little fanfare.
This will be a, “hey what was the name of that company that had the first XPO1 inhibitor company that went out of business” situation. It will be forgotten like so many others…